Synthesis and Antimicrobial Activity of New Carbohydrazide Bearing Quinoline Scaffolds in Silico ADMET and Molecular Docking Studies

References

• J. Jampilek, “Heterocycles in Medicinal Chemistry,” Molecules 24, no. 21 (2019): 3839.
   PubMed Web of Science ®Google Scholar
• N. Kerru, L. Gummidi, S. Maddila, K. K. Gangu, and S. B. Jonnalagadda, “A Review on Recent Advances in Nitrogen-containing Molecules and Their Biological Applications,” Molecules 25, no. 8 (2020): 1909.
   PubMed Web of Science ®Google Scholar
• M. M. Heravi, and V. Zadsirjan, “Prescribed Drugs Containing Nitrogen Heterocycles: An Overview,”RSC Advances 10, no.72 (2020): 44247–311.
   Google Scholar
• W.-Y. Fang, L. Ravindar, K. P. Rakesh, H. M. Manukumar, C. S. Shantharam, N. S. Alharbi, and H.-L. Qin, “Synthetic Approaches and Pharmaceutical Applications of Chloro-containing Molecules for Drug Discovery: A Critical Review,” European Journal of Medicinal Chemistry 173 (2019): 117–53.
   PubMed Web of Science ®Google Scholar
• P. N. Kalaria, S. C. Karad, and D. K. Raval, “A Review on Diverse Heterocyclic Compounds as the Privileged Scaffolds in Antimalarial Drug Discovery,” European Journal of Medicinal Chemistry 158 (2018): 917–36.
   PubMed Web of Science ®Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, V. D. Songire, A. P. Patil, and C. H. Gill, “Efficient Rapid Access to Biginelli for the Multicomponent Synthesis of 1,2,3,4-Tetrahydropyrimidines in Room-temperature Diisopropyl Ethyl Ammonium Acetate,” ACS Omega 4, no. 27 (2019): 22313–24.
   PubMed Web of Science ®Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, V. S. Dofe, J. N. Sangshetti, V. M. Khedkar, and C. H. Gill, “Rapid Construction of Substituted Dihydrothiophene Ureidoformamides at Room Temperature Using Diisopropyl Ethyl Ammonium Acetate: A Green Perspective,” ACS Omega 5, no. 45 (2020): 29055–67.
   PubMed Web of Science ®Google Scholar
• A. S. Nipate, C. K. Jadhav, A. V. Chate, T. R. Deshmukh, A. P. Sarkate, and C. H. Gill, “Synthesis and in Vitro Anticancer Activities of New 1,4‐Disubstituted‐1,2,3‐Triazoles Derivatives through Click Approach,” ChemistrySelect 6, no. 21 (2021): 5173–9.
   Web of Science ®Google Scholar
• C. Viegas-Junior,, Danuello, A. da Silva Bolzani, V. Barreiro, E. J. Fraga, C. A. M. “Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes,” Current Medicinal Chemistry 14, no. 17 (2007): 1829–52. doi:10.2174/092986707781058805
   PubMed Web of Science ®Google Scholar
• A. H. Alkhzem, T. J. Woodman, and I. S. Blagbrough, “Design and Synthesis of Hybrid Compounds as Novel Drugs and Medicines,” RSC Advances 12, no. 30 (2022): 19470–84.
   PubMed Web of Science ®Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, A. P. Patil, and C. H. Gill, “Ionic Liquid Catalyzed One-pot Multi-component Synthesis of Fused Pyridine Derivatives: A Strategy for Green and Sustainable Chemistry,” Journal of Heterocyclic Chemistry 57, no. 12 (2020): 4291–303.
   Web of Science ®Google Scholar
• A. S. Nipate, C. K. Jadhav, A. V. Chate, K. S. Taur, and C. H. Gill, “β-Cyclodextrin Catalyzed Access to Fused 1,8-Dihydroimidazo[2,3-b]Indoles via One-pot Multicomponent Cascade in Aqueous Ethanol: Supramolecular Approach toward Sustainability,” Journal of Heterocyclic Chemistry 57, no. 2 (2020): 820–9.
   Web of Science ®Google Scholar
• T. Shiro, T. Fukaya, and M. Tobe, “The Chemistry and Biological Activity of Heterocycle-fused Quinolinone Derivatives: A Review,” European Journal of Medicinal Chemistry 97, no. 1 (2015): 397–408.
   PubMedGoogle Scholar
• M. C. Mandewale, U. C. Patil, S. V. Shedge, U. R. Dappadwad, and R. S. Yamgar, “A Review on Quinoline Hydrazone Derivatives as a New Class of Potent Antitubercular and Anticancer Agents,” Beni-Suef University Journal of Basic and Applied Sciences 6, no. 4 (2017): 354–61. doi:10.1016/j.bjbas.2017.07.005
   Google Scholar
• C. K. Jadhav, A. S. Nipate, A. V. Chate, P. M. Kamble, G. A. Kadam, V. S. Dofe, V. M. Khedkar, and C. H. Gill, “Room Temperature Ionic Liquid Promoted Improved and Rapid Synthesis of Highly Functionalized Imidazole and Evaluation of Their Inhibitory Activity against Human Cancer Cells,” Journal of the Chinese Chemical Society 68, no. 6 (2021): 1067–81. doi:10.1002/jccs.202000468
   Web of Science ®Google Scholar
• K. George, P. Elavarasan, S. Ponnusamy, and K. Sathananthan, “Facile One-pot Synthesis of Functionalized Quinoline-fused Fluorescent Dihydro/Spiro-quinazolinone Derivatives,” ACS Omega 7, no. 24 (2022): 20605–18. doi:10.1021/acsomega.2c00674
   PubMed Web of Science ®Google Scholar
• C. B. Sangani, J. A. Makawana, Y.-T. Duan, Y. Yin, S. B. Teraiya, N. J. Thumar, and H.-L. Zhu, “Design, Synthesis and Molecular Modeling of Biquinoline–Pyridine Hybrids as a New Class of Potential EGFR and HER-2 Kinase Inhibitors,” Bioorganic & Medicinal Chemistry Letters 24, no. 18 (2014): 4472–6. doi:10.1016/j.bmcl.2014.07.094
   PubMed Web of Science ®Google Scholar
• O. O. Ajani, K. T. Iyaye, and O. T. Ademosun, “Recent Advances in Chemistry and Therapeutic Potential of Functionalized Quinoline Motifs – A Review,” RSC Advances 12, no. 29 (2022): 18594–614. doi:10.1039/d2ra02896d
   PubMed Web of Science ®Google Scholar
• M. Mishra, V. K. Mishra, V. Kashaw, A. K. Iyer, and S. K. Kashaw, “Comprehensive Review on Various Strategies for Antimalarial Drug Discovery,” European Journal of Medicinal Chemistry 125 (2017): 1300–20. doi:10.1016/j.ejmech.2016.11.025
   PubMed Web of Science ®Google Scholar
• E. G. Tse, M. Korsik, and M. H. Todd, “The Past, Present and Future of Anti-malarial Medicines,” Malaria Journal 18, no. 1 (2019): 93. doi:10.1186/s12936-019-2724-z
   PubMedGoogle Scholar
• B. S. Matada, R. Pattanashettar, and N. G. Yernale, “A Comprehensive Review on the Biological Interest of Quinoline and Its Derivatives,” Bioorganic & Medicinal Chemistry 32 (2021): 115973. doi:10.1016/j.bmc.2020.115973
   PubMed Web of Science ®Google Scholar
• M. F. El Shehry, M. M. Ghorab, S. Y. Abbas, E. A. Fayed, S. A. Shedid, and Y. A. Ammar, “Quinoline Derivatives Bearing Pyrazole Moiety: Synthesis and Biological Evaluation as Possible Antibacterial and Antifungal Agents,” European Journal of Medicinal Chemistry 143 (2018): 1463–73. doi:10.1016/j.ejmech.2017.10.046
   PubMed Web of Science ®Google Scholar
• S. Kumar, S. Bawa, and H. Gupta, “Biological Activities of Quinoline Derivatives,” Mini Reviews in Medicinal Chemistry 9, no. 14 (2009): 1648–54. doi:10.2174/138955709791012247
   PubMed Web of Science ®Google Scholar
• R. Kaur, and K. Kumar, “Synthetic and Medicinal Perspective of Quinolines as Antiviral Agents,” European Journal of Medicinal Chemistry 215 (2021): 113220. doi:10.1016/j.ejmech.2021.113220
   PubMed Web of Science ®Google Scholar
• Z. Diamant, E. Mantzouranis, and L. Bjermer, “Montelukast in the Treatment of Asthma and Beyond,” Expert Review of Clinical Immunology 5, no. 6 (2009): 639–58. doi:10.1586/eci.09.62
   PubMed Web of Science ®Google Scholar
• B. Furlan, B. T. de Melo, J. Z. B. Papini, M. Sperandio, J. D. Oliveira, E. de Paula, C. M. S. Cereda, and G. R. Tofoli, “Pre-clinical Evaluation of New Dibucaine Formulations for Preventive Analgesia,” Journal of Liposome Research 31, no. 3 (2021): 230–6. doi:10.1080/08982104.2020.1785494
   PubMed Web of Science ®Google Scholar
• D. Sriram, P. Yogeeswari, R. Thirumurugan, and T. Ratan Bal, “Camptothecin and Its Analogues: A Review on Their Chemotherapeutic Potential,” Natural Product Research 19, no. 4 (2005): 393–412. doi:10.1080/14786410412331299005
   PubMed Web of Science ®Google Scholar
• V. J. Venditto, and E. E. Simanek, “Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature,” Molecular Pharmaceutics 7, no. 2 (2010): 307–49. doi:10.1021/mp900243b
   PubMed Web of Science ®Google Scholar
• J. S. Frankel, and T. L. Schwartz, “Brexpiprazole and Cariprazine: Distinguishing Two New Atypical Antipsychotics from the Original Dopamine Stabilizer Aripiprazole,” Therapeutic Advances in Psychopharmacology 7, no. 1 (2017): 29–41. doi:10.1177/2045125316672136
   PubMed Web of Science ®Google Scholar
• I. A. Subhan, R. Alosaimy, N. T. Alotaibi, B. Mirza, G. Mirza, and O. Bantan, “Evaluation of Compliance Issues to Anti-glaucoma Medications before and after a Structured Interventional Program,” Cureus 14, no. 6 (2022). doi:10.7759/cureus.25943
   Web of Science ®Google Scholar
• A. S. Lader, A. Baguisi, R. Casale, S. A. Kates, and R. Beeuwkes, “CMX-2043 Mechanisms of Action In Vitro,” Journal of Cardiovascular Pharmacology 68, no. 3 (2016): 241–7. doi:10.1097/FJC.0000000000000408
   PubMed Web of Science ®Google Scholar
• K. Murugan, C. Panneerselvam, J. Subramaniam, M. Paulpandi, R. Rajaganesh, M. Vasanthakumaran, J. Madhavan, S. Shafi, S. Roni, M. Portilla-Pulido, et al, “Synthesis of New Series of Quinoline Derivatives with Insecticidal Effects on Larval Vectors of Malaria and Dengue Diseases,” Scientific Reports 12, no. 1 (2022): 4765. doi:10.1038/s41598-022-08397-5
   PubMed Web of Science ®Google Scholar
• S. Jain, V. Chandra, P. Kumar Jain, K. Pathak, D. Pathak, and A. Vaidya, “Comprehensive Review on Current Developments of Quinoline-based Anticancer Agents,” Arabian Journal of Chemistry 12, no. 8 (2019): 4920–46. doi:10.1016/j.arabjc.2016.10.009
   Web of Science ®Google Scholar
• B. Abdi, M. Fekadu, D. Zeleke, R. Eswaramoorthy, and Y. Melaku, “Synthesis and Evaluation of the Antibacterial and Antioxidant Activities of Some Novel Chloroquinoline Analogs,” Journal of Chemistry 2021, (2021): 1–13.
   Google Scholar
• G. da Rosa Monte Machado, D. Diedrich, T. C. Ruaro, A. R. Zimmer, M. Lettieri Teixeira, L. F. de Oliveira, M. Jean, P. Van de Weghe, S. F. de Andrade, S. C. Baggio Gnoatto, et al, “Quinolines Derivatives as Promising New Antifungal Candidates for the Treatment of Candidiasis and Dermatophytosis,” Brazilian Journal of Microbiology 51, no. 4 (2020): 1691–701.
   PubMed Web of Science ®Google Scholar
• D. R. Adams, J. M. Bentley, K. R. Benwell, M. J. Bickerdike, C. D. Bodkin, I. A. Cliffe, C. T. Dourish, A. R. George, G. A. Kennett, A. R. Knight, et al, “Pyrrolo(Iso)Quinoline Derivatives as 5-HT(2C) Receptor Agonists,” Bioorganic & Medicinal Chemistry Letters 16, no. 3 (2006): 677–80.
   PubMed Web of Science ®Google Scholar
• S. Mukherjee, and M. Pal, “Medicinal Chemistry of Quinolines as Emerging Anti-inflammatory Agents: An Overview,” Current Medicinal Chemistry 20, no. 35 (2013): 4386–410.
   PubMed Web of Science ®Google Scholar
• M. Foley, and L. Tilley, “Quinoline Antimalarials: Mechanisms of Action and Resistance,” International Journal for Parasitology 27, no. 2 (1997): 231–40.
   PubMed Web of Science ®Google Scholar
• R. S. Keri, and S. A. Patil, “Quinoline: A Promising Antitubercular Target,” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 68, no. 8 (2014): 1161–75. doi:10.1016/j.biopha.2014.10.007
   PubMed Web of Science ®Google Scholar
• B. Campo, O. Vandal, D. L. Wesche, and J. N. Burrows, “Killing the Hypnozoite – Drug Discovery Approaches to Prevent Relapse in Plasmodium Vivax,” Pathogens and Global Health 109, no. 3 (2015): 107–22.
   PubMed Web of Science ®Google Scholar
• P. Zajdel, K. Marciniec, A. Maślankiewicz, K. Grychowska, G. Satała, B. Duszyńska, T. Lenda, A. Siwek, G. Nowak, A. Partyka, et al, “Antidepressant and Antipsychotic Activity of New Quinoline- and Isoquinoline-sulfonamide Analogs of Aripiprazole Targeting Serotonin 5-HT1A/5-HT2A/5-HT7 and Dopamine D2/D3 Receptors,” European Journal of Medicinal Chemistry 60 (2013): 42–50.
   PubMed Web of Science ®Google Scholar
• A. Dorababu, “Quinoline: A Promising Scaffold in Recent Antiprotozoal Drug Discovery,” ChemistrySelect 6, no. 9 (2021): 2164–77.
   Web of Science ®Google Scholar
• W.-Y. Li, X.-Q. Xiong, D.-M. Zhao, Y.-F. Shi, Z.-H. Yang, C. Yu, P.-W. Fan, M.-S. Cheng, and J.-K. Shen, “Quinoline-3-Carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors,” Molecules 17, no. 5 (2012): 5497–507.
   PubMed Web of Science ®Google Scholar
• S. Rossiter, J.-M. Péron, P. J. Whitfield, and K. Jones, “Synthesis and Anthelmintic Properties of Arylquinolines with Activity against Drug-resistant Nematodes,” Bioorganic & Medicinal Chemistry Letters 15, no. 21 (2005): 4806–8.
   PubMed Web of Science ®Google Scholar
• S. Kumar Gupta, and A. Mishra, “Synthesis, Characterization & Screening for Anti-inflammatory & Analgesic Activity of Quinoline Derivatives Bearing Azetidinones Scaffolds,” Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 15, no. 1 (2016): 31–43.
   PubMedGoogle Scholar
• K. J. Bowers, E. Chow, H. Xu, R. O. Dror, M. P. Eastwood, B. A. Gregersen, J. L. Klepeis, I. Kolossvary, M. A. Moraes, F. D. Sacerdoti, J. K. Salmon, Y. Shan, and D. E. Shaw, "Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters," Proceedings of the ACM/IEEE Conference on Supercomputing, (2006), 11–17.
   Google Scholar
• H. A. Arjun, G. N. Anil Kumar, R. Elancheran, and S. Kabilan, “Crystal Structure, DFT and Hirshfeld Surface Analysis of (E)-N′-[(1-Chloro-3,4-dihydronaphthalen-2-yl)Methylidene]Benzohydrazide Monohydrate,” Acta Crystallographica Section E 76, no. 2 (2020): 132–6.
   Google Scholar
• H. A. Arjun, R. K. Rajan, R. Elancheran, M. Ramanathan, A. Bhattacharjee, and S. Kabilan, “Crystal Structure, Hirshfeld Surface Analysis, DFT and Molecular Docking Studies on Benzohydrazide Derivatives as Potential Inhibitors of Prostate Cancer,” Chemical Data Collections 26 (2020): 100350.
   Google Scholar
• H. A. Arjun, R. Elancheran, N. Manikandan, K. Lakshmithendral, M. Ramanathan, A. Bhattacharjee, N. K. Lokanath, and S. Kabilan, “Design, Synthesis, and Biological Evaluation of (E)-N’-((1-Chloro-3,4-Dihydronaphthalen-2-Yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents,” Frontiers in Chemistry 7 (2019): 474.
   Google Scholar